Month: January 2015

Cambia is a powder form of the anti-inflammatory diclofenac. Diclofenac has been available forever as a tablet, which you may know by the brand name Voltaren. It turns out that diclofenac, when taken in the faster acting solution known as Cambia, works very well at the onset of migraine. Very well and fast, within 15… Read More

Back in December we introduced you to the terms biologics and biosimilars—in a nutshell, these are specialty medications, and their (sort of) generic equivalents. You should also know that a few pharmaceutical companies have already filed applications for biosimilar drugs, hoping for approval by the FDA and bragging rights to be the first ever biosimilar… Read More

The TRUEtrack and TRUEtest blood glucose test strip boxes look nearly identical because they are both made by the same company, Nipro Diagnostics, and they can be very difficult to tell apart. The problem is that the TRUEtrack and TRUEtest strips will only work in their respective meters and cannot be interchanged, so you need… Read More

Is drinking coffee bad for me? For a drink as popular as coffee, its physiologic effects are something you should learn about. You will be reassured I’m sure. The Good Maintaining alertness is a well-known benefit and what most of us rely on caffeine for. But what else? Every day my patients ask me if… Read More

Jublia (efinaconazole) is a new medication for the topical treatment of toenail fungus, approved by the FDA in 2014 and now available in pharmacies. What is toenail fungus? Toenail fungus is an infection underneath the toenail in the skin of the nail bed. Symptoms include thickening of the toenail, discoloration, change in nail shape, loosening… Read More

If you have had stent placement after balloon angioplasty for coronary artery disease you will be placed on medications to ensure you don’t form clots inside those stents. One of them is aspirin, which you will take indefinitely after stent placement. The other one is up for debate, though most of you will take clopidogrel… Read More

This past weekend, Dr. Sharon Orrange and Sivakami Sambasivam from GoodRx were recognized by the Society of General Internal Medicine for research showing that GoodRx reduces patients’ out of pocket prescription costs and improves adherence (taking medications as prescribed). We presented to hundreds of internal medicine doctors, and received an award for our outstanding contribution… Read More

One of the biggest challenges we face at GoodRx is trying to explain to Americans how the odd, confusing world of drug pricing works. Imagine if your grocery store acted like a pharmacy. Milk can only be found behind a counter, and you have no idea how much it costs until checkout. At checkout, you find… Read More

In the past year, the realm of hepatitis C treatment has been flourishing. Several new medications have received FDA approval and have changed the way we treat this often silent disease. With the introduction of new first line treatments, slowly but surely, we will begin to see the discontinuation of many older hepatitis C treatments. Incivek… Read More

Namzaric (memantine/donepezil) is a new combination drug approved on December 24, 2014 for the treatment of moderate to severe dementia of the Alzheimer type (Alzheimer’s disease) in patients already taking Namenda XR (memantine) and Aricept (donepezil). What is Alzheimer’s disease? Alzheimer’s disease involves a decline in mental ability that is severe enough to affect daily activities. It… Read More